Published in Anticancer Drugs on September 01, 2005
PP2A: The Wolf in Sheep's Clothing? Cancers (Basel) (2015) 0.85
Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type I. Biochimie (2017) 0.75
Platinum-based anticancer agents: innovative design strategies and biological perspectives. Med Res Rev (2003) 1.17
Towards guest-zeolite interactions: an NMR spectroscopic approach. Chemistry (2002) 0.90
Anticancer activity of a series of platinum complexes integrating demethylcantharidin with isomers of 1,2-diaminocyclohexane. Bioorg Med Chem Lett (2006) 0.83
Pharmacokinetics and tissue distribution of novel traditional Chinese medicine-platinum anticancer agents in rats. J Inorg Biochem (2007) 0.79
An investigation of the roles of surface aluminum and acid sites in the zeolite MCM-22. Chemistry (2002) 0.79
DNA damage induced by novel demethylcantharidin-integrated platinum anticancer complexes. Biochem Biophys Res Commun (2007) 0.78
Impact of oxaliplatin and a novel DACH-platinum complex in the gene expression of HCT116 colon cancer cells. Oncol Rep (2008) 0.77
Differential nephrotoxicity of cisplatin and a novel series of traditional Chinese medicine-platinum anticancer agents correlates with their chemical reactivity towards sulfur-containing nucleophiles. Anticancer Drugs (2006) 0.77
Protein phosphatase 2A inhibition and circumvention of cisplatin cross-resistance by novel TCM-platinum anticancer agents containing demethylcantharidin. Bioorg Med Chem (2004) 0.76
East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes. Anticancer Agents Med Chem (2014) 0.75
Determination of the release of hydrolyzed demethylcantharidin from novel traditional chinese medicine-platinum compounds with anticancer activity by gas chromatography. J Chromatogr A (2002) 0.75
Synergistic interaction between platinum-based antitumor agents and demethylcantharidin. Cancer Lett (2004) 0.75